rs17439693

Variant summary

Our verdict is Benign. The variant received -21 ACMG points: 0P and 21B. BP4_StrongBP6_Very_StrongBP7BA1

The NM_000127.3(EXT1):​c.1431C>T​(p.Pro477Pro) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.188 in 1,611,950 control chromosomes in the GnomAD database, including 30,396 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).

Frequency

Genomes: 𝑓 0.17 ( 2554 hom., cov: 32)
Exomes 𝑓: 0.19 ( 27842 hom. )

Consequence

EXT1
NM_000127.3 synonymous

Scores

2

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:6

Conservation

PhyloP100: -0.248

Publications

20 publications found
Variant links:
Genes affected
EXT1 (HGNC:3512): (exostosin glycosyltransferase 1) This gene encodes an endoplasmic reticulum-resident type II transmembrane glycosyltransferase involved in the chain elongation step of heparan sulfate biosynthesis. Mutations in this gene cause the type I form of multiple exostoses. [provided by RefSeq, Jul 2008]
EXT1 Gene-Disease associations (from GenCC):
  • exostoses, multiple, type 1
    Inheritance: AD Classification: DEFINITIVE, STRONG Submitted by: Labcorp Genetics (formerly Invitae), G2P, ClinGen
  • chondrosarcoma
    Inheritance: AD Classification: STRONG Submitted by: Genomics England PanelApp
  • hereditary multiple osteochondromas
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -21 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.54).
BP6
Variant 8-117819781-G-A is Benign according to our data. Variant chr8-117819781-G-A is described in ClinVar as Benign. ClinVar VariationId is 255172.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BP7
Synonymous conserved (PhyloP=-0.248 with no splicing effect.
BA1
GnomAd4 highest subpopulation (NFE) allele frequency at 95% confidence interval = 0.203 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
EXT1NM_000127.3 linkc.1431C>T p.Pro477Pro synonymous_variant Exon 6 of 11 ENST00000378204.7 NP_000118.2

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
EXT1ENST00000378204.7 linkc.1431C>T p.Pro477Pro synonymous_variant Exon 6 of 11 1 NM_000127.3 ENSP00000367446.3
EXT1ENST00000437196.1 linkn.*322C>T non_coding_transcript_exon_variant Exon 5 of 10 5 ENSP00000407299.1
EXT1ENST00000684189.1 linkn.898C>T non_coding_transcript_exon_variant Exon 6 of 11
EXT1ENST00000437196.1 linkn.*322C>T 3_prime_UTR_variant Exon 5 of 10 5 ENSP00000407299.1

Frequencies

GnomAD3 genomes
AF:
0.173
AC:
26232
AN:
151990
Hom.:
2556
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.102
Gnomad AMI
AF:
0.206
Gnomad AMR
AF:
0.192
Gnomad ASJ
AF:
0.137
Gnomad EAS
AF:
0.0383
Gnomad SAS
AF:
0.122
Gnomad FIN
AF:
0.305
Gnomad MID
AF:
0.137
Gnomad NFE
AF:
0.206
Gnomad OTH
AF:
0.175
GnomAD2 exomes
AF:
0.177
AC:
44336
AN:
250746
AF XY:
0.176
show subpopulations
Gnomad AFR exome
AF:
0.103
Gnomad AMR exome
AF:
0.182
Gnomad ASJ exome
AF:
0.152
Gnomad EAS exome
AF:
0.0360
Gnomad FIN exome
AF:
0.307
Gnomad NFE exome
AF:
0.201
Gnomad OTH exome
AF:
0.190
GnomAD4 exome
AF:
0.190
AC:
277351
AN:
1459842
Hom.:
27842
Cov.:
32
AF XY:
0.189
AC XY:
136972
AN XY:
726332
show subpopulations
African (AFR)
AF:
0.104
AC:
3473
AN:
33442
American (AMR)
AF:
0.181
AC:
8109
AN:
44712
Ashkenazi Jewish (ASJ)
AF:
0.150
AC:
3910
AN:
26128
East Asian (EAS)
AF:
0.0376
AC:
1494
AN:
39700
South Asian (SAS)
AF:
0.124
AC:
10665
AN:
86212
European-Finnish (FIN)
AF:
0.306
AC:
16335
AN:
53400
Middle Eastern (MID)
AF:
0.172
AC:
896
AN:
5218
European-Non Finnish (NFE)
AF:
0.199
AC:
221483
AN:
1110730
Other (OTH)
AF:
0.182
AC:
10986
AN:
60300
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.454
Heterozygous variant carriers
0
10760
21520
32279
43039
53799
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
7502
15004
22506
30008
37510
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.173
AC:
26246
AN:
152108
Hom.:
2554
Cov.:
32
AF XY:
0.177
AC XY:
13142
AN XY:
74342
show subpopulations
African (AFR)
AF:
0.102
AC:
4249
AN:
41536
American (AMR)
AF:
0.192
AC:
2933
AN:
15282
Ashkenazi Jewish (ASJ)
AF:
0.137
AC:
477
AN:
3470
East Asian (EAS)
AF:
0.0382
AC:
198
AN:
5180
South Asian (SAS)
AF:
0.122
AC:
586
AN:
4810
European-Finnish (FIN)
AF:
0.305
AC:
3223
AN:
10554
Middle Eastern (MID)
AF:
0.137
AC:
40
AN:
292
European-Non Finnish (NFE)
AF:
0.206
AC:
13977
AN:
67958
Other (OTH)
AF:
0.177
AC:
375
AN:
2114
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.506
Heterozygous variant carriers
0
1112
2224
3335
4447
5559
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
284
568
852
1136
1420
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.184
Hom.:
6076
Bravo
AF:
0.162
Asia WGS
AF:
0.100
AC:
349
AN:
3478
EpiCase
AF:
0.198
EpiControl
AF:
0.195

ClinVar

Significance: Benign
Submissions summary: Benign:6
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

Multiple congenital exostosis Benign:2
Jan 12, 2018
Illumina Laboratory Services, Illumina
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant was observed in the ICSL laboratory as part of a predisposition screen in an ostensibly healthy population. It had not been previously curated by ICSL or reported in the Human Gene Mutation Database (HGMD: prior to June 1st, 2018), and was therefore a candidate for classification through an automated scoring system. Utilizing variant allele frequency, disease prevalence and penetrance estimates, and inheritance mode, an automated score was calculated to assess if this variant is too frequent to cause the disease. Based on the score and internal cut-off values, a variant classified as benign is not then subjected to further curation. The score for this variant resulted in a classification of benign for this disease. -

Feb 04, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

not provided Benign:2
Mar 03, 2015
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

-
Breakthrough Genomics, Breakthrough Genomics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:not provided

- -

not specified Benign:1
-
PreventionGenetics, part of Exact Sciences
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Exostoses, multiple, type 1 Benign:1
Jul 07, 2023
KCCC/NGS Laboratory, Kuwait Cancer Control Center
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.54
CADD
Benign
6.4
DANN
Benign
0.61
PhyloP100
-0.25
Mutation Taster
=100/0
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs17439693; hg19: chr8-118832020; COSMIC: COSV108236613; API